189 related articles for article (PubMed ID: 11397395)
1. First-pass metabolism of 1,3-butadiene in once-through perfused livers of rats and mice.
Filser JG; Faller TH; Bhowmik S; Schuster A; Kessler W; Pütz C; Csanády GA
Chem Biol Interact; 2001 Jun; 135-136():249-65. PubMed ID: 11397395
[TBL] [Abstract][Full Text] [Related]
2. Quantitative investigation on the metabolism of 1,3-butadiene and of its oxidized metabolites in once-through perfused livers of mice and rats.
Filser JG; Bhowmik S; Faller TH; Hutzler C; Kessler W; Midpanon S; Pütz C; Schuster A; Semder B; Veereshwarayya V; Csanády GA
Toxicol Sci; 2010 Mar; 114(1):25-37. PubMed ID: 20007191
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of 1,3-butadiene to toxicologically relevant metabolites in single-exposed mice and rats.
Filser JG; Hutzler C; Meischner V; Veereshwarayya V; Csanády GA
Chem Biol Interact; 2007 Mar; 166(1-3):93-103. PubMed ID: 16616907
[TBL] [Abstract][Full Text] [Related]
4. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice.
Csanády GA; Guengerich FP; Bond JA
Carcinogenesis; 1992 Jul; 13(7):1143-53. PubMed ID: 1638680
[TBL] [Abstract][Full Text] [Related]
6. Differences in butadiene adduct formation between rats and mice not due to selective inhibition of CYP2E1 by butadiene metabolites.
Pianalto KM; Hartman JH; Boysen G; Miller GP
Toxicol Lett; 2013 Nov; 223(2):221-7. PubMed ID: 24021170
[TBL] [Abstract][Full Text] [Related]
7. Cellular and molecular basis for species, sex and tissue differences in 1,3-butadiene metabolism.
Elfarra AA; Krause RJ; Kemper RA
Chem Biol Interact; 2001 Jun; 135-136():239-48. PubMed ID: 11397394
[TBL] [Abstract][Full Text] [Related]
8. Glutathione conjugation of 1,2:3,4- diepoxybutane in human liver and rat and mouse liver and lung in vitro.
Boogaard PJ; Sumner SC; Bond JA
Toxicol Appl Pharmacol; 1996 Feb; 136(2):307-16. PubMed ID: 8619238
[TBL] [Abstract][Full Text] [Related]
9. High concentrations of butadiene epoxides in livers and lungs of mice compared to rats exposed to 1,3-butadiene.
Himmelstein MW; Asgharian B; Bond JA
Toxicol Appl Pharmacol; 1995 Jun; 132(2):281-8. PubMed ID: 7785055
[TBL] [Abstract][Full Text] [Related]
10. In vivo doses of butadiene epoxides as estimated from in vitro enzyme kinetics by using cob(I)alamin and measured hemoglobin adducts: an inter-species extrapolation approach.
Motwani HV; Törnqvist M
Toxicol Appl Pharmacol; 2014 Dec; 281(3):276-84. PubMed ID: 25448046
[TBL] [Abstract][Full Text] [Related]
11. Insights into the toxicokinetics and toxicodynamics of 1,3-butadiene.
Bond JA; Medinsky MA
Chem Biol Interact; 2001 Jun; 135-136():599-614. PubMed ID: 11397415
[TBL] [Abstract][Full Text] [Related]
12. Development of a physiologically based toxicokinetic model for butadiene and four major metabolites in humans: global sensitivity analysis for experimental design issues.
Brochot C; Smith TJ; Bois FY
Chem Biol Interact; 2007 May; 167(3):168-83. PubMed ID: 17397815
[TBL] [Abstract][Full Text] [Related]
13. Molecular dosimetry of N-7 guanine adduct formation in mice and rats exposed to 1,3-butadiene.
Koc H; Tretyakova NY; Walker VE; Henderson RF; Swenberg JA
Chem Res Toxicol; 1999 Jul; 12(7):566-74. PubMed ID: 10409395
[TBL] [Abstract][Full Text] [Related]
14. Cob(I)alamin for trapping butadiene epoxides in metabolism with rat S9 and for determining associated kinetic parameters.
Motwani HV; Fred C; Haglund J; Golding BT; Törnqvist M
Chem Res Toxicol; 2009 Sep; 22(9):1509-16. PubMed ID: 19764821
[TBL] [Abstract][Full Text] [Related]
15. A novel DNA adduct, originating from 1,2-epoxy-3,4-butanediol, is the major DNA adduct after exposure to [2,3-(14)C]-1,3-butadiene,[4-(14)C]-1,2-epoxy-3-butane.
Boogaard PJ; van Sittert NJ; Watson WP; de Kloe KP
Chem Biol Interact; 2001 Jun; 135-136():687-93. PubMed ID: 11397423
[TBL] [Abstract][Full Text] [Related]
16. Mutational spectrum of 1,3-butadiene and metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane to assess mutagenic mechanisms.
Recio L; Steen AM; Pluta LJ; Meyer KG; Saranko CJ
Chem Biol Interact; 2001 Jun; 135-136():325-41. PubMed ID: 11397399
[TBL] [Abstract][Full Text] [Related]
17. PBPK model for butadiene metabolism to epoxides: quantitative species differences in metabolism.
Johanson G; Filser JG
Toxicology; 1996 Oct; 113(1-3):40-7. PubMed ID: 8901881
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of 1,3-butadiene: inhalation pharmacokinetics and tissue dosimetry of butadiene epoxides in rats and mice.
Himmelstein MW; Turner MJ; Asgharian B; Bond JA
Toxicology; 1996 Oct; 113(1-3):306-9. PubMed ID: 8901914
[TBL] [Abstract][Full Text] [Related]
19. The importance of 3,4-epoxy-1,2-butanediol and hydroxymethylvinyl ketone in 3-butene-1,2-diol associated mutagenicity.
Powley MW; Walker VE; Li Y; Upton PB; Swenberg JA
Chem Biol Interact; 2007 Mar; 166(1-3):182-90. PubMed ID: 17349618
[TBL] [Abstract][Full Text] [Related]
20. Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation.
Himmelstein MW; Turner MJ; Asgharian B; Bond JA
Carcinogenesis; 1994 Aug; 15(8):1479-86. PubMed ID: 8055623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]